Safety of methylene blue dye for lymphatic mapping in patients taking selective serotonin reuptake inhibitors.
暂无分享，去创建一个
[1] P. Gillman,et al. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity , 2011, Journal of psychopharmacology.
[2] Brian C. Netzel,et al. Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer-implications for use in pregnancy. , 2011, American journal of surgery.
[3] A. Degnim,et al. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. , 2008, American journal of surgery.
[4] P. Gillman,et al. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction , 2007, British journal of pharmacology.
[5] S. Standiford,et al. Methylene-blue-associated encephalopathy. , 2007, Journal of the American College of Surgeons.
[6] E. Lentsch,et al. Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization , 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[7] R. Simmons,et al. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. , 2005, American journal of surgery.
[8] Fred W Lindsay,et al. Prolonged Postoperative Disorientation After Methylene Blue Infusion During Parathyroidectomy , 2004, Anesthesia and analgesia.